148 related articles for article (PubMed ID: 4075700)
1. Cholesterol metabolism: regulatory effects of the vagus in the normal and diabetic animal.
Scott LM; Tomkin GH
Diabetes Res; 1985 Nov; 2(6):313-7. PubMed ID: 4075700
[TBL] [Abstract][Full Text] [Related]
2. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.
Reihnér E; Rudling M; Ståhlberg D; Berglund L; Ewerth S; Björkhem I; Einarsson K; Angelin B
N Engl J Med; 1990 Jul; 323(4):224-8. PubMed ID: 2114543
[TBL] [Abstract][Full Text] [Related]
3. Regulation of ovarian cholesterol metabolism: control of 3-hydroxy-3-methylglutaryl coenzyme A reductase and acyl coenzyme A:cholesterol acyltransferase.
Schuler LA; Toaff ME; Strauss JF
Endocrinology; 1981 Apr; 108(4):1476-86. PubMed ID: 7472277
[TBL] [Abstract][Full Text] [Related]
4. HMG-CoA reductase inhibition reverses LCAT and LDL receptor deficiencies and improves HDL in rats with chronic renal failure.
Liang K; Kim CH; Vaziri ND
Am J Physiol Renal Physiol; 2005 Mar; 288(3):F539-44. PubMed ID: 15507547
[TBL] [Abstract][Full Text] [Related]
5. HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LCAT, ACAT, LDL receptor, and SRB-1 in hereditary analbuminemia.
Liang K; Vaziri ND
Kidney Int; 2003 Jul; 64(1):192-8. PubMed ID: 12787409
[TBL] [Abstract][Full Text] [Related]
6. Changes in hepatic and intestinal cholesterol regulatory enzymes. The influence of metformin.
Scott LM; Tomkin GH
Biochem Pharmacol; 1983 Mar; 32(5):827-30. PubMed ID: 6838630
[TBL] [Abstract][Full Text] [Related]
7. ACAT inhibition reverses LCAT deficiency and improves plasma HDL in chronic renal failure.
Vaziri ND; Liang K
Am J Physiol Renal Physiol; 2004 Nov; 287(5):F1038-43. PubMed ID: 15280162
[TBL] [Abstract][Full Text] [Related]
8. HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, SR-B1, and ACAT in diet-induced syndrome X.
Roberts CK; Liang K; Barnard RJ; Kim CH; Vaziri ND
Kidney Int; 2004 Oct; 66(4):1503-11. PubMed ID: 15458444
[TBL] [Abstract][Full Text] [Related]
9. Effects of perturbations in hepatic free and esterified cholesterol pools on bile acid synthesis, cholesterol 7 alpha-hydroxylase, HMG-CoA reductase, acyl-CoA:cholesterol acyltransferase and cytosolic cholesteryl ester hydrolase.
Grogan WM; Bailey ML; Heuman DM; Vlahcevic ZR
Lipids; 1991 Nov; 26(11):907-14. PubMed ID: 1805095
[TBL] [Abstract][Full Text] [Related]
10. Hepatic cholesterol metabolism in estrogen-treated men.
Angelin B; Olivecrona H; Reihnér E; Rudling M; Ståhlberg D; Eriksson M; Ewerth S; Henriksson P; Einarsson K
Gastroenterology; 1992 Nov; 103(5):1657-63. PubMed ID: 1426886
[TBL] [Abstract][Full Text] [Related]
11. Age-related changes in cholesterol metabolism in macrosomic offspring of rats with streptozotocin-induced diabetes.
Merzouk H; Madani S; Boualga A; Prost J; Bouchenak M; Belleville J
J Lipid Res; 2001 Jul; 42(7):1152-9. PubMed ID: 11441144
[TBL] [Abstract][Full Text] [Related]
12. Regulation of acylcoenzyme A. Cholesterol acyltransferase and 3-hydroxy-3-methylglutaryl coenzyme A reductase activity by lipoproteins in the intestine of parabiont rats.
Purdy BH; Field FJ
J Clin Invest; 1984 Aug; 74(2):351-7. PubMed ID: 6746898
[TBL] [Abstract][Full Text] [Related]
13. Acyl-CoA: cholesterol acyltransferase and 3-hydroxy-3-methylglutaryl-CoA reductase in carp-liver microsomes: effect of cold acclimation on enzyme activities and on hepatic and plasma lipid composition.
Teichert T; Wodtke E
Biochim Biophys Acta; 1992 Dec; 1165(2):211-21. PubMed ID: 1450216
[TBL] [Abstract][Full Text] [Related]
14. Serum lipoproteins and cholesterol metabolism in two hypercholesterolaemic rabbit models.
O'Meara NM; Devery RA; Owens D; Collins PB; Johnson AH; Tomkin GH
Diabetologia; 1991 Mar; 34(3):139-43. PubMed ID: 1884884
[TBL] [Abstract][Full Text] [Related]
15. In vitro studies of lipid metabolism in human liver.
Angelin B; Reihnér E; Rudling M; Ewerth S; Björkhem I; Einarsson K
Am Heart J; 1987 Feb; 113(2 Pt 2):482-7. PubMed ID: 3812206
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of altered cholesterol metabolism in rats with spontaneous focal glomerulosclerosis.
Vaziri ND; Sato T; Liang K
Kidney Int; 2003 May; 63(5):1756-63. PubMed ID: 12675851
[TBL] [Abstract][Full Text] [Related]
17. Effects of HMG-CoA reductase inhibition on hepatic expression of key cholesterol-regulatory enzymes and receptors in nephrotic syndrome.
Vaziri ND; Liang K
Am J Nephrol; 2004; 24(6):606-13. PubMed ID: 15583480
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol metabolism in alloxan-induced diabetic rabbits.
O'Meara NM; Devery RA; Owens D; Collins PB; Johnson AH; Tomkin GH
Diabetes; 1990 May; 39(5):626-33. PubMed ID: 2332120
[TBL] [Abstract][Full Text] [Related]
19. Age-related changes in the metabolism of cholesterol in rat liver microsomes.
Ståhlberg D; Angelin B; Einarsson K
Lipids; 1991 May; 26(5):349-52. PubMed ID: 1895880
[TBL] [Abstract][Full Text] [Related]
20. Impact of an enriched-cholesterol diet on enzymatic cholesterol metabolism during rabbit gestation.
Montoudis A; Boileau S; Simoneau L; Lafond J
Life Sci; 2003 Aug; 73(11):1463-77. PubMed ID: 12850506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]